Gastro Oesophageal Reflux Disease Clinical Trial
Official title:
Influence of Wrap Fixation Technique on the Results of Fundoplication
NCT number | NCT04335734 |
Other study ID # | ONMedU 1 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | November 1, 2012 |
Est. completion date | May 28, 2019 |
Verified date | April 2020 |
Source | Odessa National Medical University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Patients who underwent anti-reflux surgery were divided into two groups. In the I group Nissen fundoplication was supplemented with suturing wrap to the crura or the body of stomach using two non-absorbable stitches on each side. Control group included patients who underwent classic Nissen fundoplication without wrap fixation. All patients were assessed before and after surgery using validated symptoms and quality of life (GERD-HRQL) questionnaires, 24-h impedance-pH monitoring and barium-swallow.
Status | Completed |
Enrollment | 138 |
Est. completion date | May 28, 2019 |
Est. primary completion date | October 1, 2014 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 20 Years to 80 Years |
Eligibility |
Inclusion Criteria: - Age: 20 - 80 years; - Gastroesophageal reflux disease as evidence by gastroscopy and pH-monitoring; - HH type I, II Exclusion Criteria: - Age < 20 years and > 80 years; - Unable to undergo laparoscopic fundoplication due to: severe comorbidities (ASA III and more), previous major surgery with severe adhesions, etc.; - HH type III, IV; - BMI < 16 and > 45 kg/m²; - Pregnancy (in females); - Oesophageal motility disorders; - Oesophageal peptic strictures; - Oesophageal diverticula, other types (i.e. non-reflux) of chronic esophagitis, connective tissue disorders (e.g. scleroderma); - History of oesophageal/gastric/duodenal surgery including vagotomy; - Relapsing course of ulcer disease/hyperacid gastritis including complicated by delayed gastric/duodenal emptying |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Grubnik Volodymyr |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Recurrence rate of hiatal hernia | Recurrence of hiatal hernia will be assessed by barium contrast swallow study | 60 months | |
Primary | Slipped wrap | Slipped wrap will be assessed by barium contrast swallow study | 60 months | |
Secondary | Quality of life and satisfaction | Quality of life and satisfaction will be assessed by Gastroesophageal reflux disease - health-related quality of life (GERD-HRQL) score. The scale has 11 items,each item is scored from 0 to 5. A higher score indicating a better quality of life. | 60 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01710995 -
A Three-Period Study to Investigate the Relative Bioavailability and Pharmacodynamic Profiles of a Zegerid 20mg Capsule, Zegerid 20mg Powder for Oral Suspension and Losec 20mg Capsule in Healthy Adult Volunteers Under Fasting Conditions
|
Phase 1 | |
Completed |
NCT05129670 -
Clinical Investigation to Assess the Acid Neutralisation Activity of a Calcite Chewing Gum
|
N/A |